news

DUBLIN–(BUSINESS WIRE)–The “Regenerative Medicine Market Size, Share & Trends Analysis By Product (Primary Cell-based, Stem & Progenitor Cell-based), By Therapeutic

LONDON–(BUSINESS WIRE)–#Biotechnology–The global Hemophilia A therapeutics market size is poised to grow by USD 4.31 billion during 2019-2023, according to

Key Hires in Quality Assurance, Medical Sciences and Regulatory Affairs MALVERN, Pa.–(BUSINESS WIRE)–#antibiotics–VenatoRx Pharmaceuticals today announced the addition of pharmaceutical

DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Packaging Market Size, Share & Trends Analysis Report By Material (Plastics & Polymers, Paper & Paperboard), By

LONDON–(BUSINESS WIRE)–#Biotechnology–The global erectile dysfunction (ED) drugs market size is poised to decline by USD 575.07 million during 2019-2023, according

DUBLIN–(BUSINESS WIRE)–The “Personalized Medicine Market Size, Share & Trends Analysis By Product (Personalized Medical Care, Therapeutics, Personalized Nutrition & Wellness),

LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus—PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical-stage biotechnology company focused on developing targeted cellular therapies for cancer

WILMINGTON, N.C.–(BUSINESS WIRE)–Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an exclusive collaboration agreement with

MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring

MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring